Acuitas US Microcap Institutional (AFMCX)
12.10
+0.29 (+2.46%)
USD |
May 26 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.50% | 48.81M | 0.00% | 78.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -1.398M | -19.00% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. The fund normally invests at least 80% of its net assets in the equity securities of microcap companies that (i) are headquartered in the U.S., or (ii) generate at least 50% of their revenue from activity in the U.S. It will pursue its investment objective using a "multi-manager" process, allocating assets among a carefully chosen group of asset managers (the "Subadvisers"). The adviser will select the fund's sub-advisers using its manager research and selection process which seeks to identify investment managers that are likely to achieve out performance over a long time horizon. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | AFMCX |
| Equity Style | Small Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Blend |
| Category Index | Russell 2000 TR USD |
| Prospectus Objective | Small Company |
| Fund Owner Firm Name | Acuitas Investments |
| Prospectus Benchmark Index | |
| Russell Micro Cap TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Christopher Tessin | 7.79 yrs |
| Dennis Jensen | 7.79 yrs |
| Matt Nieman | 1.14 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
41
-1.398M
-2.135B
Category Low
4.490B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of April 30, 2022
Performance Versus Category
As of May 26, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 26, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| First American Government Obligs X | 2.88% | 1.00 | 0.00% |
| AdvanSix Inc | 1.80% | 46.15 | 1.54% |
| UFP Technologies Inc | 1.52% | 76.40 | 2.55% |
| ePlus Inc | 1.44% | 57.52 | 0.68% |
| Meridian Bioscience Inc | 1.43% | 27.02 | 2.66% |
| The Hackett Group Inc | 1.42% | 19.74 | 0.15% |
| Harvard Bioscience Inc | 1.35% | 3.75 | 0.00% |
| Limelight Networks Inc | 1.31% | 3.58 | 1.99% |
| Photronics Inc | 1.31% | 19.74 | -1.60% |
| Agilysys Inc | 1.27% | 39.47 | 0.66% |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. The fund normally invests at least 80% of its net assets in the equity securities of microcap companies that (i) are headquartered in the U.S., or (ii) generate at least 50% of their revenue from activity in the U.S. It will pursue its investment objective using a "multi-manager" process, allocating assets among a carefully chosen group of asset managers (the "Subadvisers"). The adviser will select the fund's sub-advisers using its manager research and selection process which seeks to identify investment managers that are likely to achieve out performance over a long time horizon. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | AFMCX |
| Equity Style | Small Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Blend |
| Category Index | Russell 2000 TR USD |
| Prospectus Objective | Small Company |
| Fund Owner Firm Name | Acuitas Investments |
| Prospectus Benchmark Index | |
| Russell Micro Cap TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Christopher Tessin | 7.79 yrs |
| Dennis Jensen | 7.79 yrs |
| Matt Nieman | 1.14 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-26-22) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield (5-25-22) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 10.93 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of March 31, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 7/18/2014 |
| Last Annual Report Date | 6/30/2021 |
| Last Prospectus Date | 11/1/2021 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |